The study's findings about increased SARS-CoV-2 susceptibility add to a controversial area of research. Here's what we know from this study and the broader research landscape:
What This Study Found
- Prior vapor exposure increased SARS-CoV-2 viral load in lung tissue models
- Several key antiviral genes were suppressed after vapor exposure
- Th1 immunity (critical for fighting viral infections) was altered
Broader Research Context
- Some population studies have found associations between vaping and increased respiratory infection risk
- Other studies have not found clear associations
- A separate 2026 study in BMC Pulmonary Medicine found that even nicotine-free vaping impaired airway cilia function — the tiny hair-like structures that sweep pathogens out of the lungs
- Real-world COVID-19 data on vaping has been mixed, with some studies showing increased severity and others showing no clear effect
Bottom line on infection risk: The biological mechanisms (impaired cilia, suppressed antiviral genes, disrupted autophagy) suggest vaping could increase infection risk. But population-level evidence is inconsistent. This study adds mechanistic support but doesn't settle the question. More research in actual vapers is needed.
